- Home
- CFFI vs ACIU Comparison
CFFI vs ACIU Comparison
Compare CFFI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- ACIU
- Stock Information
- Founded
- CFFI 1927
- ACIU 2003
- Country
- CFFI United States
- ACIU Switzerland
- Employees
- CFFI N/A
- ACIU N/A
- Industry
- CFFI Major Banks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- CFFI Finance
- ACIU Health Care
- Exchange
- CFFI Nasdaq
- ACIU Nasdaq
- Market Cap
- CFFI 211.9M
- ACIU 189.1M
- IPO Year
- CFFI 1998
- ACIU 2016
- Fundamental
- Price
- CFFI $66.83
- ACIU $2.43
- Analyst Decision
- CFFI
- ACIU Strong Buy
- Analyst Count
- CFFI 0
- ACIU 1
- Target Price
- CFFI N/A
- ACIU $12.00
- AVG Volume (30 Days)
- CFFI 39.2K
- ACIU 152.3K
- Earning Date
- CFFI 07-24-2025
- ACIU 08-05-2025
- Dividend Yield
- CFFI 2.75%
- ACIU N/A
- EPS Growth
- CFFI 32.37
- ACIU N/A
- EPS
- CFFI 7.57
- ACIU N/A
- Revenue
- CFFI $122,075,000.00
- ACIU $32,014,254.00
- Revenue This Year
- CFFI N/A
- ACIU N/A
- Revenue Next Year
- CFFI N/A
- ACIU $533.21
- P/E Ratio
- CFFI $8.83
- ACIU N/A
- Revenue Growth
- CFFI 7.42
- ACIU 91.20
- 52 Week Low
- CFFI $50.70
- ACIU $1.43
- 52 Week High
- CFFI $89.90
- ACIU $4.26
- Technical
- Relative Strength Index (RSI)
- CFFI 54.39
- ACIU 73.47
- Support Level
- CFFI $62.47
- ACIU $2.02
- Resistance Level
- CFFI $69.66
- ACIU $2.15
- Average True Range (ATR)
- CFFI 1.47
- ACIU 0.13
- MACD
- CFFI 0.29
- ACIU 0.03
- Stochastic Oscillator
- CFFI 60.64
- ACIU 83.64
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.